SCHEMBL18064898

SCHEMBL18064898

O=C(OC(C(F)(F)F)C(F)(F)F)N1CCN(Cc2ccc(C(F)(F)F)cc2N2C3CCC2COC3)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 18/20 1.00
▸ ABHD6 Q9BV23 10/20 1.00
▸ PLA2G7 Q13093 5/20 0.77
▸ CYP2D6 P10635 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18087120 0.89 MGLL (0.80) MGLLABHD6PLA2G7CYP2D6
SCHEMBL29509902 0.89 MGLL (0.80) MGLLABHD6PLA2G7CYP2D6
SCHEMBL23349073 0.87 MGLL (0.77) MGLLABHD6PLA2G7CYP2D6
SCHEMBL15100813 0.84 MGLL (1.00) MGLLABHD6PLA2G7CYP2D6
SCHEMBL18064891 0.84 MGLL (0.82) MGLLABHD6PLA2G7CYP2D6
SCHEMBL22273329 0.83 MGLL (0.79) MGLLABHD6PLA2G7CYP2D6
SCHEMBL18064866 0.83 MGLL (1.00) MGLLABHD6PLA2G7CYP2D6
SCHEMBL29509888 0.83 MGLL (1.00) MGLLABHD6PLA2G7CYP2D6
Elcubragistat SCHEMBL15100632 0.82 MGLL (1.00) MGLLABHD6PLA2G7CYP2D6
SCHEMBL18064772 0.82 MGLL (0.80) MGLLABHD6PLA2G7CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3271352-B1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H LUNDBECK AS (DK) 2021-05-12 — — EP disclosed
EP-3271352-B1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H LUNDBECK AS (DK) 2021-05-12 — — EP disclosed
US-9994537-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-06-12 — — US disclosed
US-9994537-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2018-06-12 — — US disclosed
EP-3271352-A2 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME Abide Therapeutics, Inc. (US) 2018-01-24 — — EP disclosed
US-20170334874-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-23 — — US disclosed
US-20170334874-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-11-23 — — US disclosed
US-9771341-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2017-09-26 — — US disclosed
US-9771341-B2 Piperazine carbamates and methods of making and using same ABIDE THERAPEUTICS, INC. (US) 2017-09-26 — — US disclosed
US-20160272602-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2016-09-22 — — US disclosed
WO-2016149401-A2 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABIDE THERAPEUTICS, INC. (US) 2016-09-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272602-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABHD6, RABL6, ABHD16A MGLL 46/4885ABHD6 1/4885PLA2G7 204/4885
US-20170334874-A1 PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME ABHD6, RABL6, ABHD16A MGLL 46/4885ABHD6 1/4885PLA2G7 204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback